Video Experimental Relacionado
Updated: Sep 10, 2025
10:16
Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
Published on: August 17, 2022
3.4K
Avances en la investigación de vacunas de ARNm para enfermedades infecciosas
Zhen Zhang1,2, Jingli Du1, Danyang Zhang1
1Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Institute of Tuberculosis Research, Senior Department of Tuberculosis, The Eighth Medical Center of PLA General Hospital, Beijing, 100091, China.
European journal of medical research
|August 23, 2025
Resumen
Las vacunas de ARN mensajero (ARNm) ofrecen formas seguras y efectivas de prevenir enfermedades infecciosas al instruir al cuerpo para que cree proteínas patógenas. Su rápido desarrollo y despliegue, especialmente para COVID-19, destacan su potencial para la innovación de vacunas futuras.
Área de la Ciencia:
- Vacunas y vacunas
- Biología molecular
- Inmunología
Sus antecedentes:
- Las vacunas de ARN mensajero (ARNm) estimulan las respuestas inmunes dirigidas contra los patógenos.
- Presentan ventajas sobre las vacunas tradicionales en seguridad, eficacia, producción y costo.
- El éxito de las vacunas de ARNm contra el COVID-19 ha revitalizado el interés en esta tecnología.
Objetivo del estudio:
- Revisar la base molecular, los sistemas de administración y los mecanismos inmunológicos de las vacunas de ARNm.
- Resumir el progreso de la investigación y los ensayos clínicos para diversos objetivos de enfermedades infecciosas.
- Discutir los desafíos y las direcciones futuras para el desarrollo de vacunas de ARNm, particularmente para infecciones bacterianas como la tuberculosis.
Principales métodos:
- Revisión de la literatura sobre la tecnología de vacunas de ARNm.
- Análisis de datos de investigaciones y ensayos clínicos para múltiples patógenos.
- Discusión de los sistemas de entrega de nanopartículas de lípidos (LNP).
Principales resultados:
- Las vacunas de ARNm demuestran una alta seguridad y eficacia.
- La administración de nanopartículas de lípidos (LNP) es crucial para la eficacia de la vacuna de ARNm.
- Las aplicaciones exitosas incluyen COVID-19, influenza, rabia, Zika, VIH y Mycobacterium tuberculosis.
Conclusiones:
- Las vacunas de ARNm son una herramienta poderosa para combatir las enfermedades infecciosas.
- Se necesita más investigación para superar los desafíos en la aplicación de la vacuna de ARNm.
- Esta tecnología es prometedora para desarrollar vacunas contra patógenos difíciles, incluidas bacterias como M.tb.
Palabras clave:
Ensayos clínicosSistemas de suministroMecanismos inmunesComponentes de la vacuna contra el ARNMLas vacunas antirretroviralesMás Videos Relacionados
Videos de Conceptos Relacionados
01:29Microorganisms in Medicine and Therapeutics
314
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
314
02:31Nuclear Export of mRNA
7.9K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.9K
02:28Leaky Scanning
5.2K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K
00:36Viral Mutations
32.9K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.9K
02:15Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
02:22Regulated mRNA Transport
6.4K
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
6.4K